Structures by: Sulaiman O.
Total: 15
2-(1,3-Dioxoindan-2-yl)isoquinoline-1,3,4-trione
C18H9NO5
Acta Crystallographica Section E (2015) 71, 1 o6-o7
a=12.60800(10)Å b=13.6849(2)Å c=8.44670(10)Å
α=90° β=102.0510(10)° γ=90°
3β-chlorocholest-5-en-7-one
C27H43ClO
Acta Crystallographica Section E (2010) 66, 3 o688
a=11.1494(11)Å b=7.8552(8)Å c=14.6317(14)Å
α=90.00° β=109.535(2)° γ=90.00°
Indeno[1,2-b]quinoxalin-11-one
C15H8N2O
Acta Crystallographica Section E (2010) 66, 6 o1494
a=23.688(3)Å b=3.7862(5)Å c=11.5730(16)Å
α=90.00° β=90.00° γ=90.00°
Cholest-5-en-7-one
C27H44O
Acta Crystallographica Section E (2010) 66, 7 o1668
a=6.3468(13)Å b=11.517(3)Å c=15.678(3)Å
α=90.00° β=91.470(5)° γ=90.00°
Cyclohexane-1,3-diyl bis(<i>N</i>-phenylcarbamate)
C20H22N2O4
Acta Crystallographica Section E (2010) 66, 9 o2406-o2407
a=38.356(7)Å b=9.5453(16)Å c=9.8472(16)Å
α=90.00° β=91.034(3)° γ=90.00°
2,2,4-Trimethyl-7-nitro-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-5-ium perchlorate
C12H16N3O2,ClO4
Acta Crystallographica Section E (2010) 66, 7 o1845
a=21.046(7)Å b=11.818(3)Å c=15.636(6)Å
α=90.00° β=132.176(9)° γ=90.00°
Ethyl (3a-<i>cis</i>)-3a,8b-dihydroxy-2-methyl- 4-oxo-3a,8b-dihydro-4<i>H</i>-indeno[1,2-<i>b</i>]furan-3-carboxylate monohydrate
C15H14O6,H2O1
Acta Crystallographica Section E (2009) 65, 11 o2616
a=7.9740(4)Å b=16.7524(8)Å c=11.0041(5)Å
α=90.00° β=98.833(2)° γ=90.00°
3β-Chlorocholest-5-ene
C27H45Cl
Acta Crystallographica Section E (2010) 66, 6 o1249-o1250
a=21.208(2)Å b=7.5302(7)Å c=30.778(3)Å
α=90.00° β=91.453(2)° γ=90.00°
2-(4-Methylcyclohex-3-enyl)propan-2-yl <i>N</i>-phenylcarbamate
C17H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1889-o1890
a=19.3067(19)Å b=9.0058(9)Å c=8.9521(9)Å
α=90.00° β=100.964(3)° γ=90.00°
5-[(<i>E</i>)-(2-Hydroxybenzylidene)amino]-1<i>H</i>-1,3-benzimidazole- 2(3<i>H</i>)-thione
C14H11N3OS
Acta Crystallographica Section E (2011) 67, 1 o144-o145
a=8.2680(2)Å b=28.1043(6)Å c=10.5047(2)Å
α=90.00° β=92.2340(10)° γ=90.00°
<i>N</i>,<i>N</i>-Bis(3β-acetoxy-5α-cholest-6-ylidene)hydrazine
C58H96N2O4
Acta Crystallographica Section E (2011) 67, 2 o522-o523
a=9.5892(4)Å b=16.1622(6)Å c=19.5255(7)Å
α=65.832(2)° β=89.562(2)° γ=81.364(2)°
9-(3,4-Dimethoxyphenyl)-3,3,6,6-tetramethyl-4,5,6,9-tetrahydro- 3<i>H</i>-xanthene-1,8(2<i>H</i>,7<i>H</i>)-dione
C25H30O5
Acta Crystallographica Section E (2011) 67, 7 o1719-o1720
a=9.4895(7)Å b=10.2283(7)Å c=23.3218(16)Å
α=85.872(4)° β=86.537(4)° γ=74.425(3)°
2-Methyl-5-nitro-1<i>H</i>-benzimidazole monohydrate
C8H7N3O2,H2O
Acta Crystallographica Section E (2011) 67, 6 o1523-o1524
a=6.9051(10)Å b=7.1309(11)Å c=10.0653(15)Å
α=79.421(3)° β=73.062(3)° γ=67.517(3)°
Cholest-5-ene
C27H46
Acta Crystallographica Section E (2011) 67, 6 o1368
a=10.6938(2)Å b=19.4062(3)Å c=11.1763(2)Å
α=90.00° β=93.6630(10)° γ=90.00°
3β-Acetoxy-5α-cholestan-6-one 2-cyanoacetylhydrazone
C32H51N3O3
Acta Crystallographica Section E (2012) 68, 2 o473-o474
a=17.1691(2)Å b=9.66940(10)Å c=19.1447(3)Å
α=90.00° β=109.1710(10)° γ=90.00°